EUVIMEDEUVIMED entdecken
Crossref

Differentiation of 2-, 3-, and 4-fluorofuranylfentanyl using high performance liquid chromatography–mass spectrometry and human liver microsomes

Takaharu Iwaki, Yasuhisa Oida, Miku Morikawa, Kousuke Itoh, Kosei Iwai, Konosuke Abe, Erina Kohyama, Tetsuro Ito, Hiroyuki Tanaka, Tsuyoshi Yokoi, Kiyoyuki Kitaichi iD

Journal of Analytical Toxicology · 04.06.2026 · 50 (6)

DOI: 10.1093/jat/bkag056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 30.06.2026. Verfasst von Takaharu Iwaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Division, Gifu Prefectural Research Institute for Health and Environmental Sciences, Kakamigahara, 504-0838, Japan. Hauptthemen laut MEDLINE: Microsomes, Liver, Fentanyl. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Health and Labour Sciences Research Grant 2021-2023, Research on Regulatory Science of Pharmaceuticals and Medical Devices.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The structural similarity of positional isomers of fentanyl analogs makes their forensic differentiation difficult, particularly when the parent compounds exhibit similar chromatographic behavior and product-ion spectra. This study evaluated the differentiation of 2-, 3-, and 4-fluorofuranylfentanyl (2-, 3-, and 4-FFF) using high-performance liquid chromatography–mass spectrometry (HPLC-MS) and human liver microsomes (HLMs). The synthesized positional isomers were analyzed using gas chromatography–mass spectrometry (GC–MS), high-performance liquid chromatography–tandem mass spectrometry (HPLC–MS/MS), and HPLC–ion trap–time-of-flight mass spectrometry (HPLC–IT–TOF–MS). Although the parent isomers were separated by GC–MS, their retention times and product-ion spectra obtained by HPLC–MS/MS were highly similar under the present conditions. Incubation with HLMs supplemented with NADPH, UDPGA, and alamethicin produced three Phase I metabolic categories: an oxidative N-dealkylated metabolite of FFF (M1), monohydroxylated FFF metabolites (M2a and M2b), and an amide hydrolysis product of FFF (M3). Glucuronide conjugates were not detected under the present analytical conditions. Although M1 was the predominant metabolite, M1 did not retain the complete FFF structure. M2a and M2b were putatively assigned as monohydroxylated metabolites that retained the complete FFF structure, and may therefore support the differentiation of FFF positional isomers, although their retention times did not allow the differentiation. M3, which did not retain the complete FFF structure, showed distinct retention times among the three positional isomers, providing chromatographic information useful for metabolite-based differentiation. The in vitro elimination half-lives differed among 2-, 3-, and 4-FFF under the present HLM conditions, suggesting possible differences in the pharmacokinetic properties of these positional isomers. These findings indicate that HPLC–MS analysis using HLMs provides useful analytical information for differentiating FFF positional isomers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Microsomes, LiverFentanylHumansChromatography, High Pressure LiquidTandem Mass SpectrometryIsomerismGas Chromatography-Mass SpectrometryLiquid Chromatography-Mass Spectrometry

Substanzen

Fentanyl

Autor:innen und Institutionen

  • Health Science Division, Gifu Prefectural Research Institute for Health and Environmental Sciences, Kakamigahara, 504-0838, Japan.
  • Laboratory of Pharmaceutics, Department of Biomedical Pharmaceutics, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.
  • Laboratory of Pharmacognosy, Department of Pharmacy, Faculty of Pharmacy, Gifu University of Medical Science, Gifu, 509-0293, Japan.
  • Laboratory of Immunobiology, Department of Biofunctional Analysis, Gifu Pharmaceutical University, Gifu, 501-1196, Japan.

ORCID-Profile: Kiyoyuki Kitaichi

Förderung

  • Health and Labour Sciences Research Grant 2021-2023
  • Research on Regulatory Science of Pharmaceuticals and Medical Devices

Zitieren

APA

Iwaki, T., Oida, Y., Morikawa, M., Itoh, K., Iwai, K., Abe, K., Kohyama, E., Ito, T., Tanaka, H., Yokoi, T., & Kitaichi, K. (2026). Differentiation of 2-, 3-, and 4-fluorofuranylfentanyl using high performance liquid chromatography–mass spectrometry and human liver microsomes. Journal of Analytical Toxicology, 50(6). https://doi.org/10.1093/jat/bkag056

Vancouver

Iwaki T, Oida Y, Morikawa M, Itoh K, Iwai K, Abe K, et al. Differentiation of 2-, 3-, and 4-fluorofuranylfentanyl using high performance liquid chromatography–mass spectrometry and human liver microsomes. Journal of Analytical Toxicology. 2026;50(6). doi:10.1093/jat/bkag056

BibTeX
@article{Iwaki2026,
  author = {Iwaki, Takaharu and Oida, Yasuhisa and Morikawa, Miku and Itoh, Kousuke and Iwai, Kosei and Abe, Konosuke and Kohyama, Erina and Ito, Tetsuro and Tanaka, Hiroyuki and Yokoi, Tsuyoshi and Kitaichi, Kiyoyuki},
  title = {Differentiation of 2-, 3-, and 4-fluorofuranylfentanyl using high performance liquid chromatography–mass spectrometry and human liver microsomes},
  journal = {Journal of Analytical Toxicology},
  year = {2026},
  volume = {50},
  number = {6},
  doi = {10.1093/jat/bkag056}
}
Kostenlos starten →